201 related articles for article (PubMed ID: 24750683)
1. Commonalities and contrasts in recent guidelines for lupus anticoagulant detection.
Moore GW
Int J Lab Hematol; 2014 Jun; 36(3):364-73. PubMed ID: 24750683
[TBL] [Abstract][Full Text] [Related]
2. Recent guidelines and recommendations for laboratory detection of lupus anticoagulants.
Moore GW
Semin Thromb Hemost; 2014 Mar; 40(2):163-71. PubMed ID: 24500573
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.
Kanouchi K; Narimatsu H; Ohnuma O; Morikane K; Fukao A
Int J Hematol; 2017 Aug; 106(2):206-211. PubMed ID: 28390037
[TBL] [Abstract][Full Text] [Related]
4. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
Moore GW; Savidge GF
Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
[TBL] [Abstract][Full Text] [Related]
5. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
[TBL] [Abstract][Full Text] [Related]
6. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
7. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
[TBL] [Abstract][Full Text] [Related]
8. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
Moore GW; Peyrafitte M; Dunois C; Amiral J
Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
[TBL] [Abstract][Full Text] [Related]
9. Further evidence of false negative screening for lupus anticoagulants.
Moore GW; Henley A; Greenwood CK; Rangarajan S
Thromb Res; 2008; 121(4):477-84. PubMed ID: 17602725
[TBL] [Abstract][Full Text] [Related]
10. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
11. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
12. New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests.
Martinuzzo ME; Cerrato GS; Varela ML; Adamczuk YP; Forastiero RR
Int J Lab Hematol; 2012 Apr; 34(2):208-13. PubMed ID: 22032515
[TBL] [Abstract][Full Text] [Related]
13. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.
Depreter B; Devreese KM
Clin Chem Lab Med; 2016 Sep; 54(9):1511-6. PubMed ID: 26894579
[TBL] [Abstract][Full Text] [Related]
14. Frequent false-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin.
Martinuzzo ME; Barrera LH; D 'adamo MA; Otaso JC; Gimenez MI; Oyhamburu J
Int J Lab Hematol; 2014 Apr; 36(2):144-50. PubMed ID: 24034808
[TBL] [Abstract][Full Text] [Related]
15. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
Hong SK; Hwang SM; Kim JE; Kim HK
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
[TBL] [Abstract][Full Text] [Related]
17. Screening for lupus anticoagulants in patients treated with vitamin K antagonists.
Isert M; Miesbach W; Stoever G; Lindhoff-Last E; Linnemann B
Int J Lab Hematol; 2015 Dec; 37(6):758-65. PubMed ID: 26224222
[TBL] [Abstract][Full Text] [Related]
18. Practice and performance of lupus anticoagulant tests: A single centre experience.
Tay Za K; Jayaranee S; Shanmugam H
Malays J Pathol; 2020 Apr; 42(1):51-57. PubMed ID: 32342930
[TBL] [Abstract][Full Text] [Related]
19. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
[TBL] [Abstract][Full Text] [Related]
20. Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients.
Moore GW
Thromb J; 2007 Sep; 5():12. PubMed ID: 17822554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
